Plain-English translation of NCT02932007 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Atrial Fibrillation research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This is a small pilot study testing whether can help stop persistent atrial fibrillation (an irregular heartbeat condition) within 2 weeks of treatment. Researchers want to see if this medication could serve as an alternative to electrical shock therapy for converting the heart back to a normal rhythm. You would take the medication by mouth for 14 days while being monitored.
Many patients with persistent irregular heartbeat struggle with current treatment options, which often involve electrical cardioversion (a shock to the heart) or other medications that don't always work well. This study explores whether this medication could offer patients another choice for stopping their symptoms.
You likely qualify if…
You likely don't qualify if…
You would take the medication by mouth for 14 days total: 2 tablets per day for the first 2 days, then 1 tablet per day for the remaining 12 days. Your heart rhythm would be monitored closely during this 2-week period, either through a pacemaker/device you already have or by wearing a portable heart monitor provided by the study. The researchers will check whether the treatment stops your irregular heartbeat and assess any side effects.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
United States